Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 20/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 19/20 | 0.70 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.70 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14438224 | 0.92 | HSP90AB1 (0.71) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| SCHEMBL14438226 | 0.86 | HSP90AB1 (0.72) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| SCHEMBL3396906 | 0.84 | HSP90AB1 (0.67) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| Biib021 SCHEMBL29394202 | 0.82 | HSP90AA1 (1.00) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| Biib021 SCHEMBL29409214 | 0.82 | HSP90AA1 (1.00) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| Biib021 SCHEMBL29351570 | 0.82 | HSP90AA1 (1.00) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| Biib021 SCHEMBL1791028 | 0.82 | HSP90AA1 (1.00) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| SCHEMBL3396228 | 0.81 | HSP90AB1 (0.71) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| SCHEMBL14438216 | 0.81 | HSP90AB1 (0.67) | HSP90AB1HSP90AA1HSP90B1TRAP1 | |
| SCHEMBL3396053 | 0.81 | HSP90AB1 (1.00) | HSP90AB1HSP90AA1HSP90B1TRAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1670802-A2 | NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS | Conforma Therapeutic Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005028434-A2 | NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS | CONFORMA THERAPEUTICS CORPORATION (US) | 2005-03-31 | — | — | WO | disclosed |